CClinicalTrials.gg
CompletedNCT05022953Updated Aug 26, 2021

The Effect of Digital Storytelling on Nursing Students' Compliance

An interventional study of Education, dijital storytelling in Education, Isolation and Nursing Students, sponsored by Karadeniz Technical University. Completed at 1 site in Turkey. Open to participants aged 21 Years to 22 Years. Per ClinicalTrials.gov, last updated 2021-08-26.

Sponsored by Karadeniz Technical University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Jan 2021, registered Aug 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
109
Allocation
Randomized
Ages
21 Years to 22 Years
Sex
All
01

Study summary

This study investigated the effect of digital storytelling on nursing students' compliance with isolation precautions and their knowledge levels.This was a pretest-posttest open-label randomized controlled trial. The nursing department of the faculty of health sciences of a university in the eastern Black Sea region of Turkey. The sample consisted of 109 fourth-year nursing students divided into groups of experimental (n=66) and control (n=43). Data were collected using a demographic characteristics questionnaire, an Isolation Knowledge Test (IKT), a Questionnaire of Students' Opinions on Digital storytelling (QSODS), and the Scale of Compliance with Isolation Precautions (SKIP). The experimental group attended a digital storytelling activity (intervention), while the control group received an education based on the curriculum. The data were analyzed using the Mann-Whitney U test, the Wilcoxon test, the Analysis of variance (ANOVA), and the Spearman correlation test.

02

Conditions studied

  • Education
  • Isolation
  • Nursing Students
03

In context

Lead sponsor

Karadeniz Technical University is the lead sponsor of 145 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 22 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Being voluntary
  • Having access to the Internet

Exclusion criteria

Exclusion Criteria:

  • Not attending the digital storytelling activity (intervention)
  • Not taking the posttest
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
109 participants (actual)

Study arms

  • Experimental
    Digital Story Group

    Digital Story Group: One of the researchers gave the experimental group participants a 15-minute briefing on how to perform digital storytelling. She also told them not to talk to the control group participants about the content of the briefing. She created a Pixton account (https://edu.pixton.com/educators/) and a class named "Isolation." She sent the link (https://join.pixton.com/x5xb6) to the experimental group participants. She asked them to click on the link and make stories out of their knowledge of isolation in four weeks.

    Other: Education, dijital storytelling

  • No intervention
    Control Group

    Control group participants did not go through any training in isolation.

Interventions

  • OtherEducation, dijital storytelling

    Digital story

06

What researchers measure

Primary outcomes

  1. Distribution of students according to descriptive characteristics.

    The 11-item demographic characteristics questionnaire was based on a literature review conducted by the researchers (Özden and Özveren, 2016; Orabi, 2017; Sarier and Kurşun, 2020). The experimental and control group participants had a mean age of 22.57±2.28 and 21.79±0.80, respectively. The experimental group consisted of 56 women and ten men. The control group consisted of 38 women and six men

    Time frame: 1 month

Secondary outcomes

  1. The difference between the pre, post and follow-up knowledge scores of the control and experimental group students

    The Isolation Knowledge Test (IKT) was based on a literature review conducted by the researchers (Erden et al., 2015, Doğanay et al., 2013, Karabay et al., 2018). Three experts in nursing fundamentals were consulted to develop the test. The draft test consisted of 40 statements. A pilot study was conducted to check for the intelligibility and relevance of the statements and to calculate item difficulty and item discrimination indices. was a significant difference between pretest and posttest IKT scores in the experimental group (p=0.01). There was also a significant difference between posttest and follow-up IKT scores in the experimental group (p=0.01). The experimental group had significantly higher follow-up IKT scores than pretest scores.

    Time frame: 1 month

  2. The difference between the control and experimental group scores according to the total and sub-dimensions of the scale

    The Scale of Compliance with Isolation Precautions (SCIP) was developed by Tayran and Ulupınar (2011). The scale consists of 18 items scored on a five-point Likert-type scale ("1 = Strongly disagree," "2 = Disagree," "3 = Neither agree nor disagree," "4 = Agree," "5 = Strongly agree"). The scale has a Cronbach's Alpha of 0.85 (Tayran \& Ulupınar, 2011), which was 0.86 (pretest) and 0.78 (posttest) in the present study. There was no significant difference in pretest SCIP scores between the experimental and control groups. However, there was a significant difference in posttest SCIP scores between them. The experimental group had significantly higher posttest SCIP scores than pretest scores (p=0.00). It had significantly higher follow-up SCIP scores than posttest and pretest scores. There was no significant difference between the control group's pretest, posttest, and follow-up SCIP scores

    Time frame: 2 months

  3. The following are quotations from the experimental group participants about digital storytelling.

    The Questionnaire of Students' Opinions on Digital Storytelling (QSODS) consisted of three open-ended questions on (1) the contribution of digital storytelling to learning, (2) the effect of digital storytelling on students' compliance with isolation precautions and knowledge levels, and (3) students' opinions about digital storytelling. The following are quotations from the experimental group participants about digital storytelling. "I realized that I had some gaps in my knowledge of isolation methods and protective measures. It \[digital storytelling\] helped me fill those gaps." \[Student (S). 10\]. I think that it's \[digital storytelling\] fun and instructive. I helped me go over what I already knew and learn new stuff (S.12). We've had distance learning for a long time, so this storytelling thing helped me feel like I was in it" (S. 54).

    Time frame: 2 months

07

Study locations

1 site
  • Sule BIYIK BAYRAM
    Trabzon, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 26, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05022953
Lead sponsor
Karadeniz Technical University
Responsible party
Sule BIYIK BAYRAM (Assistant Professor, Karadeniz Technical University) — Principal investigator
First posted
Aug 26, 2021
Start date
Jan 10, 2021
Primary completion
May 10, 2021
Completion
May 30, 2021
Last update
Aug 26, 2021

Study contacts

Emel Gulnar, PhD
study chair · Kırıkkale University
Nurcan Caliskan, PhD
study chair · Gazi University
Cigdem Torun Kılıc, Msc
study chair · Karadeniz Teknik University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion